U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339735) titled 'A Study of LY4064809 in Healthy Adult Participants' on Jan. 06.
Brief Summary: The purpose of this study is to find out how much LY4064809 gets into the blood stream and how long it takes the body to get rid of it when it is given as two formulations. For each participant, the study will last about nine weeks. Participants will remain in the clinical research center for about one month.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: LY4064809 Test Formulation
Administered orally
DRUG: LY4064809 Reference Formulation
Administered orally
Recruitment Status: NOT_YET...